Guided Therapeutics, Inc. (GTHP)

OTCMKTS · Delayed Price · Currency is USD

0.300

-0.030 (-9.09%)

Mar 6, 2026, 1:50 PM EST

213.48% (1Y)

Market Cap	32.17M
Revenue (ttm)	178.00K
Net Income (ttm)	-2.80M
Shares Out	91.92M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	10,648
Open	0.301
Previous Close	0.330
Day's Range	0.300 - 0.330
52-Week Range	0.064 - 0.540
Beta	0.56
RSI	48.34
Earnings Date	Mar 27, 2026

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the marketing and sale of LuViva, an advanced cervical scan non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorpo... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1992

Employees 4

Stock Exchange OTCMKTS

Ticker Symbol GTHP

Full Company Profile

Financial Performance

In 2024, Guided Therapeutics's revenue was $7,000, a decrease of -92.86% compared to the previous year's $98,000. Losses were -$2.59 million, -31.07% less than in 2023.

Financial Statements

News

There is no news available yet.